Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ellen Heitzer

Showing results (91-100 of 143) with videos related to

Pageof 15
Sort By:
Journal of Hematology & Oncology|September 2, 2022
Somatic copy number alteration and fragmentation analysis in circulating tumor DNA for cancer screening and treatment monitoring in colorectal cancer patientsAriane Hallermayr, Tobias Wohlfrom, Verena Steinke-Lange, et al.
Nature Communications|June 23, 2016
Whole-genome plasma sequencing reveals focal amplifications as a driving force in metastatic prostate cancerPeter Ulz, Jelena Belic, Ricarda Graf, et al.
International Journal of Cancer|March 26, 2018
Genomic alterations in plasma DNA from patients with metastasized prostate cancer receiving abiraterone or enzalutamideJelena Belic, Ricarda Graf, Thomas Bauernhofer, et al.
Journal of Medical Genetics|November 10, 2019
Novel phenotypes observed in patients with <i>ETV6</i>-linked leukaemia/familial thrombocytopenia syndrome and a biallelic <i>ARID5B</i> risk allele as leukaemogenic cofactorAnna Karastaneva, Karin Nebral, Axel Schlagenhauf, et al.
International Journal of Cancer|September 7, 2017
G protein-coupled receptor GPR55 promotes colorectal cancer and has opposing effects to cannabinoid receptor 1Carina Hasenoehrl, David Feuersinger, Eva M Sturm, et al.
Genome Medicine|February 24, 2020
Cell-free DNA analysis reveals POLR1D-mediated resistance to bevacizumab in colorectal cancerQing Zhou, Samantha O Perakis, Peter Ulz, et al.
Journal of Pain and Symptom Management|July 17, 2012
Computer-based symptom assessment is feasible in patients with advanced cancer: results from an international multicenter study, the EPCRC-CSAMarianne Jensen Hjermstad, Hanne C Lie, Augusto Caraceni, et al.
Molecular Oncology|June 13, 2024
Clinical applications of next-generation sequencing-based ctDNA analyses in breast cancer: defining treatment targets and dynamic changes during disease progressionEva Valentina Klocker, Samantha Hasenleithner, Rupert Bartsch, et al.
Scientific Reports|May 20, 2017
MUG-Mel2, a novel highly pigmented and well characterized NRAS mutated human melanoma cell lineBeate Rinner, Greta Gandolfi, Katharina Meditz, et al.
British Journal of Cancer|November 10, 2021
Sensitive and robust liquid biopsy-based detection of PIK3CA mutations in hormone-receptor-positive metastatic breast cancer patientsChristoph Suppan, Ricarda Graf, Stephan Jahn, et al.
Pageof 15

Showing results (91-100 of 143) with videos related to

Sort By:
Pageof 15
Journal of Hematology & Oncology|September 2, 2022
Somatic copy number alteration and fragmentation analysis in circulating tumor DNA for cancer screening and treatment monitoring in colorectal cancer patientsAriane Hallermayr, Tobias Wohlfrom, Verena Steinke-Lange, et al.
Nature Communications|June 23, 2016
Whole-genome plasma sequencing reveals focal amplifications as a driving force in metastatic prostate cancerPeter Ulz, Jelena Belic, Ricarda Graf, et al.
International Journal of Cancer|March 26, 2018
Genomic alterations in plasma DNA from patients with metastasized prostate cancer receiving abiraterone or enzalutamideJelena Belic, Ricarda Graf, Thomas Bauernhofer, et al.
Journal of Medical Genetics|November 10, 2019
Novel phenotypes observed in patients with <i>ETV6</i>-linked leukaemia/familial thrombocytopenia syndrome and a biallelic <i>ARID5B</i> risk allele as leukaemogenic cofactorAnna Karastaneva, Karin Nebral, Axel Schlagenhauf, et al.
International Journal of Cancer|September 7, 2017
G protein-coupled receptor GPR55 promotes colorectal cancer and has opposing effects to cannabinoid receptor 1Carina Hasenoehrl, David Feuersinger, Eva M Sturm, et al.
Genome Medicine|February 24, 2020
Cell-free DNA analysis reveals POLR1D-mediated resistance to bevacizumab in colorectal cancerQing Zhou, Samantha O Perakis, Peter Ulz, et al.
Journal of Pain and Symptom Management|July 17, 2012
Computer-based symptom assessment is feasible in patients with advanced cancer: results from an international multicenter study, the EPCRC-CSAMarianne Jensen Hjermstad, Hanne C Lie, Augusto Caraceni, et al.
Molecular Oncology|June 13, 2024
Clinical applications of next-generation sequencing-based ctDNA analyses in breast cancer: defining treatment targets and dynamic changes during disease progressionEva Valentina Klocker, Samantha Hasenleithner, Rupert Bartsch, et al.
Scientific Reports|May 20, 2017
MUG-Mel2, a novel highly pigmented and well characterized NRAS mutated human melanoma cell lineBeate Rinner, Greta Gandolfi, Katharina Meditz, et al.
British Journal of Cancer|November 10, 2021
Sensitive and robust liquid biopsy-based detection of PIK3CA mutations in hormone-receptor-positive metastatic breast cancer patientsChristoph Suppan, Ricarda Graf, Stephan Jahn, et al.
Pageof 15